GABELLI & Co INVESTMENT ADVISERS, INC. - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 1 filers reported holding F-STAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI & Co INVESTMENT ADVISERS, INC. ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$898,135
+19.3%
142,110
-3.4%
0.19%
+94.9%
Q3 2022$753,000
+4.0%
147,100
+27.2%
0.10%
+5.4%
Q2 2022$724,000115,6500.09%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 714,285$6,136,0001.28%
Boxer Capital, LLC 1,751,428$15,045,0000.53%
Atlas Venture Advisors, Inc. 574,996$4,939,0000.51%
Monashee Investment Management LLC 400,000$3,436,0000.41%
Connolly Sarah T. 53,001$455,0000.37%
Rock Springs Capital Management LP 1,054,232$9,056,0000.18%
Eversept Partners, LP 100,000$859,0000.06%
Maven Securities LTD 144,932$1,257,0000.05%
Point72 Asset Management, L.P. 1,075,000$9,234,0000.04%
Private Capital Advisors, Inc. 13,083$112,0000.02%
View complete list of F-STAR THERAPEUTICS INC shareholders